Patient Says AbbVie's New Trial Needs To Be On All Claims
By Rachel Graf ( February 20, 2018, 10:01 PM EST) -- A patient has urged an Illinois federal court to order a new trial on all of his claims rather than maintain its decision to hold a new trial on just one claim in the first bellwether case to reach a verdict in multidistrict litigation over testosterone replacement therapies including AbbVie Inc.'s AndroGel, noting the court determined the jury verdict awarding him $150 million in punitive damages was inconsistent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.